ThromBio is a drug discovery company whose mission is to advance the global standard of care for the treatment of stroke using novel anti-thrombotic drugs with unprecedented safety and efficacy.
Leadership:
ThromBio’s programme is driven by international leaders in drug discovery & development, experimental biomedicine, global clinical trials capability and commercialisation.
Our Lead Candidate: TBO-309
TBO-309 represents an Australian drug development success story, that has resulted in a novel antiplatelet compound with truly remarkable properties.
Lead Indications:
Acute Ischaemic stroke remains the second largest cause of death and disability globally, with 85% of all strokes caused by blood clots that block blood flow to the brain.
TBO-309 is currently being trialled in patients in Phase II clinical trials, as an adjunct to thrombolysis (STARS).
Publications:
ThromBio’s technology is built around state-of-the-art science and technology, published by internationally recognised leaders in the field of drug discovery & and experimental biomedicine.
Media:
ThromBio’s technology has received global attention for its breakthrough scientific studies.
Contact us on social@thrombio.com.au or for more information look at our website.
Company Details
- Employees
- 8
- Founded
- 2020
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.thrombio.com.au
- Keywords
- biotechnology, biotechnology research, reasearch in stroke, stroke drug, Thrombio holdings, medical research, drug development, drug discovery, anti-thrombotic drug, Australian drug development, medical treatment development, TBO-309, TBO-309 drug, clinical trials, thrombolysis, experimental biomedicine, biomedicine, breakthrough scientific studies, breakthroughs in medicine, stroke research, ThromBio.
Thrombio Questions
Thrombio's website is https://www.thrombio.com.au
Thrombio's LinkedIn profile is https://www.linkedin.com/company/thrombioholdings
Thrombio has
8 employees.
View email and phone details for 8
employees at Thrombio.
Thrombio's industry is
Biotechnology Research
Thrombio's categories are Biotechnology Research
Thrombio's founding year is 2020
